According to Zacks, “Safeguard Scientifics, Inc. is a diversified information technology company that develops, operates and manages emerging growth information technology companies. The company is currently focusing on emerging opportunities in eCommerce, enterprise applications, and network infrastructure, all of which are expected to benefit from the growing use of the Internet as a fundamental business tool. The company works closely with our partnership companies to provide numerous operational and management services to build value in preparation for public rights offerings and beyond. “
Separately, ValuEngine upgraded shares of Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 8th.
Safeguard Scientifics (NYSE:SFE) last posted its earnings results on Thursday, November 7th. The asset manager reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.56) by $0.44. On average, research analysts anticipate that Safeguard Scientifics will post 1.71 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Campbell & CO Investment Adviser LLC bought a new stake in shares of Safeguard Scientifics in the 3rd quarter worth $115,000. Dalton Greiner Hartman Maher & Co. bought a new position in Safeguard Scientifics during the third quarter valued at about $454,000. Morgan Stanley grew its position in Safeguard Scientifics by 15.2% during the second quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock valued at $241,000 after buying an additional 2,630 shares during the period. Rock Creek Group LP bought a new position in Safeguard Scientifics during the second quarter valued at about $604,000. Finally, Vanguard Group Inc. grew its position in Safeguard Scientifics by 13.5% during the second quarter. Vanguard Group Inc. now owns 1,291,339 shares of the asset manager’s stock valued at $15,586,000 after buying an additional 153,584 shares during the period. Hedge funds and other institutional investors own 67.76% of the company’s stock.
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Recommended Story: Producer Price Index (PPI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.